-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓USDISIN US09075V1026-
BioNTechBörse Börse FrankfurtWKNEURSymbol 22UA
-
BioNTechBörse Xetra FrankfurtEURSymbol 22UA
-
BioNTech SE - ADRBörse Börse BerlinEURSymbol 22UA
-
BioNTech SE - ADRBörse Börse MünchenEURSymbol 22UA
-
BIONTECH SE-ADRBörse Börse StuttgartEURSymbol 22UA
-
BIONTECH SE-ADRBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol 22UA
-
BIONTECH SE-ADRBörse Börse HamburgEURSymbol 22UA
-
BIONTECH SE-ADRBörse Quotrix System der Börse DüsseldorfEURSymbol 22UA
-
BIONTECH SE-ADRBörse Börse DüsseldorfEURSymbol 22UA
-
BIONTECH SE-ADRBörse Gettex System der Börse MünchenEURSymbol 22UA
-
ISIN US09075V1026 WKN: A2PSR2USDSymbol BNTX
-
BioNTech SE - ADRBörse Bolsa Mexicana de Valore Mexiko-StadtMXNISIN US09075V1026
-
BioNTech SE - ADRBörse Bolsa Mexicana de Valore Mexiko-Stadt
-
BioNTech SEBörse London Stock Exchange
-
ISIN US09075V1026
WKN A2PSR2
Symbol BNTX
Währung
USD
Firmenname
BioNTech SE
Marktkapitalisierung
26.221.596.672
Mitarbeiter
3.165 (+- 43%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
1.800 oder 4.530 Mitarbeiter
KGV
-99999.99
EBITDA 0
PEGRatio None
Buchwert None
BioNTech outperformed den DAX um +966 % vom 10.10.2019 bis 02.09.2022
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 299,9 EUR +1,45%
Letzte Communitymeinungen
- 5 User waren zuletzt bullisch
- Im Beta-Tester Jahresendrally Battle 2021
-
SaLyn
14.09.2021
-
Karamellsaus_55
29.08.2021
-
Zockrat
29.08.2021
Ein User hat BioNTech abonniert.
Aktionärsstruktur der BioNTech SE
Portrait der BioNTech Aktie
Das Unternehmen BioNTech SE aus Deutschland beschäftigt 3.165 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie tätig.
Die BioNTech Aktie konnte seit dem 10.10.2019 eine Rendite von sage und schreibe 970% erwirtschaften und mit dieser Performance den deutschen Leitindex DAX um 966% outperformed, der im gleichen Zeitraum 4% erwirtschaften konnte.
Mit einem Streubesitz von lediglich 19,7% ist der free float der Aktie vergleichsweise gering. Ein genauerer Blick in die Aktionärsstruktur könnte nützlich sein um den geringen Streubesitz vielleicht aufzuklären.
Das Unternehmen BioNTech SE ist nur in 5 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter VanEck Vectors Biotech ETF gewichtet BioNTech mit 6,85% im ETF.
5 ETFs die in BioNTech investieren
Dir gefallen die Informationen zu BioNTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu BioNTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu BioNTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu BioNTech?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
349 News & Informationen zur BioNTech Aktie
Pfizer, BioNTech expand covid-19 vaccine manufacturing into Latin America
Deal would allow Brazil’s Eurofarma to produce at least 100 million doses annually for distribution in the region
Crude oil prices decline on fuel demand worries; WTI trades below $68 a barrel
Crude oil prices are expected to trade sideways to up for the day with resistance at $69 and support at $65 per barrel.
Pfizer, BioNTech sign LOI with Brazil's Eurofarma to make COVID-19 vaccines for use in Latin America
Pfizer Inc. undefined and BioNTech SE undefined said Thursday that they have signed a letter of intent (LOI) with Brazil-based biopharmaceutical company…
Dollar Up, But Near One-Week Low as COVID-19 Concerns Ease By Investing.com
Dollar Up, But Near One-Week Low as COVID-19 Concerns Ease
Taiwan says BioNTech shots available earlier than expected
TAIPEI — Taiwan’s government said BioNTech SE COVID-19 vaccines are available earlier than expected and it is striving to obtain them in competition with other…
Pfizer Seeks FDA Approval For COVID-19 Vaccine Booster
(RTTNews) – Pfizer Inc. (PFE) is seeking an approval from the U.S. Food and Drug Administration for its booster dose of COVID-19 vaccine. Pfizer …
U.S. likely to approve COVID-19 boosters at 6 months after vaccination
Federal regulators are likely to approve a COVID-19 booster shot for vaccinated adults starting at least six months after the previous dose rather than the…
U.S. plans COVID-19 booster shots at six months instead of eight – WSJ
U.S. health regulators could approve a third COVID-19 shot for adults beginning at least six months after full vaccination, instead of the previously announced…
Heart inflammation risk boosted slightly by vaccine, more by COVID-19
Heart inflammation risk boosted slightly by vaccine, more by COVID-19 – study
U.S. set to approve COVID-19 booster shots at six months: WSJ
Pfizer seeks U.S. approval for COVID vaccine booster
Pfizer Inc on Wednesday said a booster dose of its two-shot COVID-19 vaccine spurs a more than threefold increase in antibodies against the coronavirus, as the…
Moderna : U.S. plans COVID-19 booster shots at six months instead of eight – WSJ
U.S. health regulators could approve a
third COVID-19 shot for adults beginning at least six months
after full vaccination, instead of the previously announced
eight-month gap, the Wall Street Journal… | August 25, 2021
Delta Air Lines to impose $200 monthly surcharge for unvaccinated employees, add testing requirements
Airline will add charge for unvaccinated employees enrolled in healthcare plan
Is This the Time for Crude Oil & Energy ETFs?
Oil prices soared lately on news of zero new cases in China, U.S. FDA's full approval of Pfizer-BioNTech Covid-19 vaccine and the moderate strength in…
BioNTech, Pfizer initiate application for approval of a third dose of their COVID-19 vaccine
BioNTech SE undefined and Pfizer Inc. undefined said Wednesday that they initiated an application to U.S. regulators for a third dose of Comirnaty, their…
Delta Air Lines to impose $200 monthly surcharge for unvaccinated employees in health care plan
Delta Air Lines Inc. is stepping up efforts to get employees vaccinated against Covid-19, introducing measures including weekly testing requirements and a…
Delta Air Lines to Impose $200 Monthly Surcharge for Unvaccinated Employees, Add Testing Requirements
The airline will add the charge for unvaccinated employees enrolled in its healthcare plan.
Moderna completes BLA submission for full approval of COVID-19 vaccine
Shares of Moderna Inc. undefined rallied 4.0% in morning trading Wednesday after the biotechnology company said it has completed the submission to the Food…
J&J says an extra dose of its COVID-19 vaccine can boost antibody levels
Johnson & Johnson is the latest drug maker to make the case that an extra dose of its COVID-19 shot can help boost antibody levels—by at least nine times…
J&J says new data indicates an extra dose of its COVID-19 vaccine can boost antibody levels
Shares of Johnson & Johnson undefined gained 0.8% in premarket trading on Wednesday after the company shared interim clinical data that indicates Americans…
Gold slips on firm dollar, risk appetite; Fed symposium in focus
Gold prices fell on Wednesday, weighed by an uptick in the dollar and buoyant risk appetite, as investors awaited Federal Reserve Chairman Jerome Powell’s…
FDA’s COVID Vaccine Approval Makes Challenges to Mandates Tougher to Win
Formal U.S approval of the Pfizer Inc /BioNTech SE COVID-19 vaccine will make it nearly impossible to successfully challenge mandates by employers, legal
Gold slips as dollar claws up, risk appetite improves
Gold prices fell on Wednesday as an uptick in the dollar and buoyant risk appetite dimmed the safe-haven metal’s appeal, while investors awaited Federal…
U.S. COVID-19 vaccine approval is 'seismic' shift for legality of mandates, experts say By Reuters
U.S. COVID-19 vaccine approval is 'seismic' shift for legality of mandates, experts say
Goldman Requires Vaccines for Employees, Visitors Entering Its Offices
The Wall Street firm also said in an employee memo that it was instituting a mask requirement for all common areas starting Wednesday.
Goldman Sachs to mandate COVID vaccine for staff, visitors at U.S. offices -memo
Goldman Sachs Group Inc told employees that from Tuesday anyone entering its offices in the United States must be fully vaccinated against COVID-19, according…
Salesforce, Snowflake, Ulta Beauty: 3 Things to Watch By Investing.com
Salesforce, Snowflake, Ulta Beauty: 3 Things to Watch
European shares end flat as Fed fears, virus concerns weigh
European stocks ended flat on Tuesday as investors held back from making big bets ahead of an update on U.S. monetary policy, even as data outlined a…
Hopes of Moderna (MRNA) Vaccine Approval Boost Biotech
Biotech ETFs shot higher after the FDA formally approved Pfizer's vaccine. Trade the group's two largest funds with these tactical ideas.
Now that a COVID-19 shot is fully approved, employer mandates are rolling in. But will vaccination rates in the U.S. go up?
The long-awaited (and for some, much-debated) approval of BioNTech and Pfizer’s COVID-19 is here, and the employer mandates are already rolling in.
Crude Oil Higher; Mexican Fire Hits Output By Investing.com
Crude Oil Higher; Mexican Fire Hits Output
Another Day, Another Record High For Futures As China Stocks Bounce, Brent Back Over $70
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
Bulls push Sensex, Nifty higher for second day straight; here’s what experts make of today’s trade
S&P BSE Sensex ended the day 403 points or 0.73% higher at 55,958 points while the NSE Nifty zoomed 0.78% to close at 16,624.
KLCI closes at two-month high after third straight day of gains
The FBM KLCI marched higher for the third straight trading session to close at its two-month high, as investors collected oversold stocks following the recent selldown.
Coronavirus tally: Daily average for new cases, deaths and hospitalizations keep climbing to multi-month highs
The global tally for the coronavirus-borne illness climbed to above 212.61 million as of early Tuesday, while death toll rose to 4,442,545, according to data…
BioNTech : Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older (Form 6-K)
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older
… | August 24, 2021
North American Morning Briefing: Tech Gains -2-
Scott Ruesterholz, portfolio manager at Insight Investment, said speculation about tapering may cause intermittent spikes in bond yields. However, the asset manager remains opportunistic because…
Top 5 High-Yielding Stock Market Gainers YTD With More Upside
Stocks Analysis by Zacks Investment Research covering: ConocoPhillips, MetLife Inc, Pfizer Inc, American International Group Inc. Read Zacks Investment Research's latest article on Investing.com
60 Biggest Movers From Yesterday
Gainers Trillium Therapeutics Inc. (NASDAQ:TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pf…
European shares extend recovery; travel stocks gain
The pan-European STOXX 600 index rose 0.3% by 0711 GMT after last week's sell-off knocked it lower by 3% from its record highs.